In line with these results, levels of circulating miRNAs were analyzed in patients with primary ITP after treatment with TPO-RAs (romiplostim or eltromboplag) over 12 weeks [89]. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.